EYLEA HD Injection Approved by FDA for Treatment of Wet Age-Related Macular Degeneration (WAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)
August 18, 2023 at 6:35 PM EDT Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection 2 mg that were maintained with fewer injections First and only treatment [...]